FFA
PACB icon

Farther Finance Advisors’s Pacific Biosciences PACB Stock Holding History

Farther Finance Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$526 Sell
222
-52
-19% -$73 ﹤0.01% 5742
2026
Q2 		$461 Sell
274
-1,282
-82% -$1.86K ﹤0.01% 5551
2026
Q1 		$2.1K Buy
1,556
+1,047
+206% +$1.87K ﹤0.01% 4885
2025
Q4 		$952 Buy
509
+391
+331% +$751 ﹤0.01% 4924
2025
Q3 		$151 Hold
118
– – ﹤0.01% 4776
2025
Q2 		$146 Sell
118
-83
-41% -$96 ﹤0.01% 4256
2025
Q1 		$227 Hold
201
– – ﹤0.01% 3928
2024
Q4 		$368 Sell
201
-15
-7% -$29 ﹤0.01% 3506
2024
Q3 		$367 Sell
216
-5
-2% -$8 ﹤0.01% 3495
2024
Q2 		$265 Buy
221
+63
+40% +$127 ﹤0.01% 3432
2024
Q1 		$577 Buy
158
+46
+41% +$269 ﹤0.01% 2972
2023
Q4 		$1.1K Sell
112
-764
-87% -$6.25K ﹤0.01% 2686
2023
Q3 		$7.32K Hold
876
– – ﹤0.01% 1393
2023
Q2 		$11.7K Sell
876
-1,076
-55% -$13.1K ﹤0.01% 1147
2023
Q1 		$22.6K Buy
+1,952
New +$19.4K 0.01% 859

Other funds holding PACB

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.82B AUM 21.33% 1-Year Est. Return
DWM
DKM Wealth Management Stockton, California $158M AUM 11.62% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's PACB Position: Q3 2026 in Review

Farther Finance Advisors reduced its Pacific Biosciences (PACB) stake by 19% in Q3 2026, selling an estimated $73 and leaving 222 shares worth $526. The position accounts for ﹤0.01% of the portfolio, ranked #5742.

Farther Finance Advisors first reported a position in PACB in Q1 2023 and has held it in 15 quarters since. The position peaked at $22.6K in Q1 2023. 6 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Farther Finance Advisors held 222 shares of Pacific Biosciences worth $526 as of Q3 2026.
  • Farther Finance Advisors sold 52 Pacific Biosciences shares in Q3 2026, an estimated $73.
  • Pacific Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5742 holding.
  • Farther Finance Advisors first reported a position in Pacific Biosciences in Q1 2023 and has held it in 15 quarters since.
  • Farther Finance Advisors's Pacific Biosciences position peaked at $22.6K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.